Kyverna Therapeutics
KYTX
KYTX
111 hedge funds and large institutions have $301M invested in Kyverna Therapeutics in 2026 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 31 increasing their positions, 35 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
6% less capital invested
Capital invested by funds: $321M → $301M (-$20.2M)
11% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 35
20.32% less ownership
Funds ownership: 77.93% → 57.62% (-20%)
Holders
111
Holding in Top 10
6
Calls
$1.41M
Puts
$468K
Top Buyers
| 1 | +$4.17M | |
| 2 | +$3.92M | |
| 3 | +$3.43M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.82M |
| 5 |
BlackRock
New York
|
+$2.77M |
Top Sellers
| 1 | -$9.72M | |
| 2 | -$5.64M | |
| 3 | -$4.18M | |
| 4 |
HCM
Heights Capital Management
San Francisco,
California
|
-$2.56M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.83M |
